FDA: Adverse reactions to vaccine shots ‘very low’

FDA records over 60K suspected adverse reactions out of 33M vaccine shots

MANILA, Philippines — The Food and Drug Administration (FDA) said Thursday it recorded 60,703 adverse reactions associated with the COVID-19 vaccine, which is still extremely low and well within global standards.

Of that number, 2,083 were suspected serious adverse reaction reports, according to FDA Director-General Eric Domingo.

“Out of the 33 million shots, about 0.18 percent ang nakita natin na mayroong suspected adverse reaction reports and ‘yung mas maliit, 0.006 percent are serious adverse reaction reports,” Domingo announced.

(Out of the 33 million shots, about 0.18 percent were suspected adverse reaction reports, and 0.006 percent were serious adverse reaction reports.)

“So, this is very low. Well within global standards for vaccination,” he added.

Citing FDA’s adverse event following immunization data, Domingo said that the COVID-19 vaccine brand with the most adverse reactions listed is AstraZeneca.

“One out of every 200 Filipino na nagpa-inject ng AstraZeneca may nararamdaman. Usually, ‘yung pananakit ng katawan, pain sa injection site, fever for maybe a day, mga sinat-sinat, pamimigat ng katawan,” Domingo mentioned.

(One out of every 200 Filipinos who received AstraZeneca experienced adverse events. Usually, body pains, pain on the injection site, fever for maybe a day, light fever, heavy feeling.)

The following are the number of total adverse events logged per vaccine brand as of August 29:

AstraZeneca – 30,202 out of 6,032,390 doses administered

Sinovac – 24,148 out of 18,583,548 doses administered

Pfizer – 2,597 out of 3,182,582 doses administered

Johnson & Johnson – 2,327 out of 3,569,162 doses administered

Moderna – 778 out of 1,683,282 doses administered

Sputnik V – 651 out of 327,125 doses administered

Sinopharm – zero out of 9,133 doses administered

RELATED STORIES

WHO urges COVID-19 vaccine booster moratorium until 2022

Villar pushes for incentives for the fully-vaccinated

52% of NCR target population fully vaccinated vs COVID-19 — Galvez

je
Read more...